FDA Letter API

Vitang Technology LLC

Letter data

Company
Vitang Technology LLC
Recipient
Ronald Jiang | Owner & CEO | Vitang Technology LLC | 14622 Franklin Ave Ste H | Tustin | , | CA | 92780-7224 | United States | info@vitangtechnology.com | ron@vitangtechnology.com
Issue date
2024-07-23
Posted date
Not available
FDA office
Center for Devices and Radiological Health
Subject
Not available
Product
Medical Devices
CMS ID
653455
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Vitang Technology LLC MARCS-CMS 653455 — July 23, 2024 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Product: Medical Devices Recipient: Recipient Name Ronald Jiang Recipient Title Owner & CEO Vitang Technology LLC 14622 Franklin Ave Ste H Tustin , CA 92780-7224 United States info@vitangtechnology.com ron@vitangtechnology.com Issuing Office: Center for Devices and Radiological Health United States Secondary Issuing Offices United States Dr. Mr. Jiang, The Food and Drug Administration has completed an evaluation of your corrective actions in response to Warning Letter #653455 dated 6/12/2023. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jessica Mu Compliance Branch Director Office of Medical Devices and Radiological Health Operations Division 3/West Content current as of: 07/31/2024 Regulated Product(s) Medical Devices